1. Injectable Graphene Oxide/Graphene Composite Supramolecular Hydrogel for Delivery of Anti-Cancer Drugs
- Author
-
Xiuxia Chen, Chengbin Pan, Hu Xiaohong, Dan Li, and Huaping Tan
- Subjects
Materials science ,Polymers and Plastics ,Graphene ,Composite number ,technology, industry, and agriculture ,Oxide ,Nanotechnology ,macromolecular substances ,General Chemistry ,Dynamic mechanical analysis ,Poloxamer ,complex mixtures ,law.invention ,chemistry.chemical_compound ,chemistry ,law ,Drug delivery ,Self-healing hydrogels ,Materials Chemistry ,Ceramics and Composites ,Solubility - Abstract
Injectable hydrogels have attracted a lot of attention in drug delivery, however, their capacity to deliver water-insoluble or hydrophobic anti-cancer drugs is limited. Here, we developed injectable graphene oxide/graphene composite supramolecular hydrogels to deliver anti-cancer drugs. Pluronic F-127 was used to stabilize graphene oxide (GO) and reduced graphene oxide (RGO) in solution, which was mixed with α-cyclodextrin (α-CD) solution to form hydrogels. Native hydrogel was used as control. GO or RGO slightly shortened gelation time. The storage and loss moduli of the hydrogels were tracked by dynamic force measurement. The storage modulus of GO or RGO composite hydrogels was larger than that of the native hydrogel. Hydrogels were unstable in solution and eroded gradually. GO or RGO in Pluronic F-127 solution could potentially improve the solubility of the water-insoluble anti-cancer drug camptothecin (CPT), especially with large drug-loaded CPT amount. Drug release behaviors from solutions and hydroge...
- Published
- 2014
- Full Text
- View/download PDF